| __timestamp | Bausch Health Companies Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 7459000 |
| Thursday, January 1, 2015 | 582800000 | 11831000 |
| Friday, January 1, 2016 | 455000000 | 25705000 |
| Sunday, January 1, 2017 | 366000000 | 46181000 |
| Monday, January 1, 2018 | 414000000 | 59497000 |
| Tuesday, January 1, 2019 | 471000000 | 65003000 |
| Wednesday, January 1, 2020 | 452000000 | 74506000 |
| Friday, January 1, 2021 | 465000000 | 126006000 |
| Saturday, January 1, 2022 | 529000000 | 126215000 |
| Sunday, January 1, 2023 | 604000000 | 120161000 |
Unleashing insights
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Bausch Health Companies Inc. and Protagonist Therapeutics, Inc. have shown contrasting approaches to R&D investment.
Bausch Health, a major player in the industry, has consistently increased its R&D spending, peaking at approximately $604 million in 2023, a 145% increase from 2014. This robust investment underscores their commitment to maintaining a competitive edge.
In contrast, Protagonist Therapeutics, a smaller biotech firm, has also ramped up its R&D efforts, reaching around $126 million in 2022, a staggering 1,590% increase from 2014. This rapid growth highlights their aggressive pursuit of innovation.
These spending patterns reflect the strategic priorities of each company, with Bausch focusing on steady growth and Protagonist on rapid expansion.
Research and Development: Comparing Key Metrics for argenx SE and Protagonist Therapeutics, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Bio-Techne Corporation and Protagonist Therapeutics, Inc.
Exelixis, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Halozyme Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
Pharming Group N.V. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Grifols, S.A. and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Bausch Health Companies Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Protagonist Therapeutics, Inc.
Research and Development Expenses Breakdown: Veracyte, Inc. vs Protagonist Therapeutics, Inc.
Research and Development Investment: Protagonist Therapeutics, Inc. vs Evotec SE